Aduro is a cancer immunotherapy company with three technology platforms developing products designed to ignite the immune system. Aduro’s technology platforms are uniquely positioned to cover the entire cancer-immunity cycle: vaccination, immune checkpoint inhibition and targeting the tumor microenvironment.